Alopecia in Patients With Autoimmune Hepatitis Treated by Tacrolimus Therapy

The document discusses the occurrence of alopecia in patients with autoimmune hepatitis who are undergoing treatment with tacrolimus therapy. The study highlights a potential side effect of tacrolimus, which is commonly used as an immunosuppressant in managing autoimmune hepatitis. The authors, affiliated with institutions in Türkiye and Sweden, emphasize the need for clinicians to be aware of this possible adverse effect when prescribing tacrolimus to patients. The article is published in the Turkish Journal of Gastroenterology, indicating its relevance to the field of gastroenterology and liver diseases.